Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study Cover

Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study

Radiology and Oncology

Volume 57 (2023): Issue 2 (June 2023)

By:

Haidara Almansour, Fritz Schick, Marcel Nachbar, Saif Afat, Victor Fritz, Daniela Thorwarth, Daniel Zips, Felix Bertram, Arndt-Christian Müller, Konstantin Nikolaou, Ahmed E Othman and Daniel Wegener

Open Access

|Jun 2023

Metrics

DOI: https://doi.org/10.2478/raon-2023-0020 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 184 - 190

Submitted on: Jan 20, 2023

Accepted on: Mar 30, 2023

Published on: Jun 21, 2023

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 times per year

Keywords:

prostate carcinoma,

adaptive radiotherapy,

image guidance,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2023 Haidara Almansour, Fritz Schick, Marcel Nachbar, Saif Afat, Victor Fritz, Daniela Thorwarth, Daniel Zips, Felix Bertram, Arndt-Christian Müller, Konstantin Nikolaou, Ahmed E Othman, Daniel Wegener, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 57 (2023): Issue 2 (June 2023)Next article